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Widespread use of the Sabin live attenuated poliovirus vaccine has had tremendous impact
on the disease worldwide, virtually eliminating it from a number of countries, including the
United States. Early proof of its safety and effectiveness was presented in 1959 by Russian
investigators, who had staged massive trials in the USSR, involving millions of children. Their
positive results were at first viewed in the United States and elsewhere with some skepticism,
but the World Health Organization favored proceeding with large-scale trials, and responded
to the claims made by Russian scientists by sending a representative to the USSR to review in
detail the design and execution ofthe vaccine programs and the reliability oftheir results. The
report that followed was a positive endorsement of the findings and contributed to the
acceptance of the Sabin vaccine in the United States, where it has been the polio vaccine of
choice since the mid-1960s.
Too often the field of health policy is considered the exclusive domain of
governmental actions, whetherlegislative orexecutive. As a result the private sector,
whether represented by voluntary organizations or professional associations, is
either ignored or considered a well-organized but inadequate proponent of enlight-
ened public action. An exception to such patterns lies in events leading to the
acceptance of the two vaccines for immunization against poliomyelitis. Here, policy
was influenced by a variety of bodies and diverse factors. Two important consider-
ations influencing the scientific community and public reaction were the sites and
sponsorship oflarge field trials. The killedvirusvaccine developed by Dr. Jonas Salk
had been tested in the United States largely under the sponsorship of the National
Foundation for Infantile Paralysis. Its success was widely heralded (particularly by
the Foundation), and itwas promptly licensed in 1955.
By 1957, Dr. Albert Sabin's live attenuated poliovirus vaccine had undergone a
number of successful field tests and had reached the stage when large trials were
indicated. Such trials were recommended by the World Health Organization Expert
Committee on Poliomyelitis inJulyof 1957. But in the United Statesthe Salkvaccine
was proving to be successful, reducing the incidence of poliomyelitis to several
thousand cases per year. Leaders of the National Foundation were therefore
satisfied and notinterested insupporting atrialofthe Sabin oralvaccine, norwasthe
United States Public Health Service. Dr. Sabin then turned to his colleagues abroad,
including those in the USSR and Czechoslovakia [1]. He supplied enoughvaccine to
immunize many thousands of children in these places and also provided seed lots
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fromwhichthe Russians quicklyprepared some tenmillion doses. Bythefall of 1959,
millions ofchildren in the Soviet Republics had received the Sabinvaccine.
Strongly positive results in terms of safety and effectiveness of the oral vaccine
were reported bythe Russian scientists at the First International Conference on Live
Poliovirus Vaccines, held in Washington, DC, at the Pan American branch ofWHO
in June 1959 [2,3]. The findings stimulated great interest and lively discussion at the
meeting, but in the United States there was some skepticism concerning reliability of
the data, particularly in relation to surveillance of vaccinees and their contacts, a
necessity for assuring vaccine safety. The fear concerned the stability of the live
attenuated virus. In the course of multiplication in the intestinal tract, some
mutation was known to occur. The frequency of contact infections raised the
possibility that serial passage might ultimately result in emergence of neurovirulent
virus strains. Although the Russian investigators had reported no significant changes
in pathogenicity for monkeys after ten human passages [3], there was still some
unease about the problem.
It was at this point (August 1959) that I was asked by WHO to visit the USSR,
Czechoslovakia, and Poland to engage in a detailed evaluation ofthe quality ofwork
in the laboratories involved, the care with which vaccinees were followed, and the
standards employed to assure the vaccine's safety. After a six-week investigation of
these aspects in several Soviet Republics, Czechoslovakia, and Poland, a detailed
analysis was submitted to WHO. While this report was not published, it was
distributed widely. Its positive assessment contributed to a rebirth of interest in the
oral vaccine and paved the way for large field trials in the United States, leading to
licensure of oral vaccine in 1961-62. Because of the importance of this 124-page
report, and because of Arthur Viseltear's interest in the background of policy
decisions concerning preventive programs, as illustrated in his work on swine
influenza [4], a precis of the findings in several USSR Republics appears in this
paper. It is presented in the present tense, as it was written, recording observations
made in the fall of 1959. As one can deduce from the report, the extraordinary
massive immunization programs developed in the various Republics were possible
because of the strengths of the then-existing sociopolitical organizations of the
USSR.
ITINERARY AND AIMS
The period between August 30 and October 11 was spent in the Soviet Union,
largely in Moscow, with visits to other areas, including Leningrad, Tashkent, and
Riga. An attempt was made to review and evaluate the following features in
connection withvaccination programs in the different areas:
1. Standards and quality oflaboratorywork
2. Selection ofareas to be vaccinated
3. Selection ofvaccinees
4. Pre-vaccinal serological surveys
5. Conduct ofvaccination
6. Surveillance, clinical and laboratory
7. Preliminary results, as ofOctober 1959'
'Some additional data have been received from the USSR since October 1959.
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HISTORY OF POLIOMYELITIS IN THE USSR
Published accounts on this subject are rare indeed, and few statistics were
available. The following information was obtained from a recent report by Dr. O.V.
Baroian, epidemiologist ofthe Ivanovsky Institute.
Beginning in the latterpart of the nineteenth century, the first sporadic cases and
small outbreaks of poliomyelitis were registered in Latvia, Estonia, and in St.
Petersburg. Smallepidemics continued in these and other areas, increasing gradually
in size during the firstquarter ofthe twentieth century. By 1929, however, compared
with European countries, the USSR still had much the lowest incidence of the
disease-0.54 per 100,000, compared with rates of 1.7 in Germany, 6.3 in Denmark,
and 15.4 in Sweden. There was no significant change in the picture until shortly after
World War II, when suddenly large first epidemics began to appear in various
Republics, and the annual rate rose steadily. Between theyears 1954-1959, poliomy-
elitis was reported in virtually all Republics of the Soviet Union, the highest
incidence being in the central and northwest, particularly the Baltic Republics, and
the lowest in the southern and southeast regions. In spite of marked differences
between various Republics, there had been a steady overall increase, from 2.8 per
100,000 in 1954, to 8.7 in 1955, and 9.4 in 1957.
LIVE VIRUS VACCINE WORK DIRECTED BY DR. M.P. CHUMAKOV
InstituteforPoliomyelitisResearch, AcademyofMedical Sciences, Moscow
The major activities concerning the live poliovirus vaccination program in the
Soviet Union are now carried on in Moscow at this Institute, under the direction of
Dr. M.P. Chumakov. Various aspects offield and laboratory work were discussed in
detail at the Institute with Dr. Chumakov and his associates.
The Poliomyelitis Research Institute was established in Moscow in 1955 because
of the increasing importance of poliomyelitis, the sudden appearance of first
epidemics in variousparts ofthe USSR, and a steadily rising incidence of the disease
generally. Dr. Chumakov, who had been head of the Viral Disease Section of the
Institute of Neurology, became the director, his laboratory forming the nucleus of
the new Institute. The Institute was visited in 1956 by members of the American
Medical Mission on Microbiology and Epidemiology [5]; since then, work on
poliomyelitis has beengreatlyexpanded, and the Institute nowconsists ofthree large
divisions,widelyseparatedphysically, all intemporary and makeshift quarters. Much
of thevirological work is done at Sokolinaya Gora, where the laboratories are in a
separate building on the grounds of the Second Infectious Disease Hospital of
Moscow. The director's office and the administrative unit are here, and the first
Salk-type vaccine was produced here in 1957. Another laboratory is at Shipok, a
40-minute drive to the other side of the city. This site is Dr. Chumakov's original
laboratory, and some of his early colleagues, such as Dr. Belajeva, still work there.
There are about sixphysicians plus their technicians, doing virological and serologi-
cal workconnectedwith thevaccinationprogram in different parts ofthis laboratory.
Dr. S.G. Drosdov, an extremely able and dynamic person, has recently been made
chief of the Epidemiology Laboratory at Shipok. In addition, the Department of
Neuropathology, which isresponsible for the examination ofmonkeys used in safety
tests of the oral vaccine, is also at Shipok, with Dr. Robinzon as director; her staff
consists offive neuropathologists, including Dr. Tufanov, who visited the U.S.A. in
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1959. The third laboratory is in Vnukovo, approximately 30 kilometers from the city,
and five kilometers from the main Moscow airport. At Vnukovo, in a clearing in a
birch forest, the new home for the Institute is under construction. This structure will
be an enormous building, with three or four wings extending from the main section,
and many carefully planned laboratories. The several animal houses are in separate
smaller buildings. They are well designed and well equipped indeed. The new
building should be completed within a few months, and the three units of the
Institute will then be brought together.
Laboratory Work
A striking feature of laboratory work at the Poliomyelitis Research Institute and
generally in the Soviet Union is the large staffavailable, both scientific and technical.
It is the usual practice for two technicians to work together, sitting on opposite sides
ofa table, one assisting the other at every step. Myimpression was that there were at
least two persons for every one in our laboratories.
Although the present laboratories ofthe Institute are old and dark, the standards
of sterile technique are universally high. In all, space is divided into sterile cubicles,
or "boxes" as they are called, each with a work table in the middle, often a sink, and
with ultraviolet light overhead. Access to the sterile cubicle is usually through an
intermediate, glass-enclosed passageway, separated from the open area of the
laboratory or from the corridor. Sterile gowns, caps, and masks are worn at all times
by all personnel entering the work cubicles. Apparently very little contamination of
tissue cultures, eitherbacterial or fungal, is encountered, using this system.
In connection with the live virus vaccine programs, much discussion centered
around methods employed in the collection, storing, shipping, and testing ofvarious
materials. The methods in all these areas were standard, with the usual minor
variations which occur from one laboratory to the next. Stool specimens were
employed for virus isolations rather than rectal swabs. All specimens collected in
Estonia were taken or sent to a central poliomyelitis laboratory in the Microbiology
Institute in Tallinn, where they were made into 20 percent suspensions and frozen.
Some specimens (a few hundred) were tested in this local laboratory, but the
majority-several thousands-were shipped to Moscow by air. During the winter, it
was not necessary to ice the shipments, but,beginning inApril, allwere packed in dry
ice for the trip. In Moscow, the work was carried out at Sokolinaya Gora under the
direction of Dr. Drosdov and 11 members of his group, five physicians and six
technicians. The method ofpreparation and testingoffecal material was the same as
that employed in United States laboratories.
Neutralization Tests
The pH (metabolic) test for neutralizing antibodies is employed using MK cells,
and Earle's media with lactalbumin and calf serum. Small, flat-bottomed insulin
bottles are being substituted for tubes, a great saving in incubator space. The tests
that I saw were clear-cut withgood, sharp color end points.
VACCINATION PROGRAMS IN DIFFERENT REPUBLICS
As reported by Chumakov et al. at the Washington Live Poliovirus Conference, in
June 1959, the first large-scale programs were carried out by his group in Estonia,
Lithuania, and Kazakhstan. Subsequently, a number of programs have been set up,
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TABLE 1
Administration ofSabin Oral Poliovirus Vaccine in
Soviet Republics, January-October 1959
Approximate Number
Republic Vaccinated
Estonian SSR 716,000
Lithuanian SSR 547,952
Kazakh SSR 1,500,000
Uzbek SSR 1,867,000
Khirgiz SSR 500,000
Tadzhik SSR Not known
Russian Federation 2,250,000
Ukrainian SSR 1,000,000
Trans-Caucasian Republics
Georgian SSR
Armenian SSR 1,600,000 (in progress)
Azerbaijan SSR
8,380,952+
vaccinating chiefly persons under 15 years. As of October 1959, part, or almost the
entire designated age group of the population within most of the Republics, had
been vaccinated. The total number of vaccinees was approximately 10,000,000, as
indicated in Table 1.
Planning for vaccination was greatly facilitated by the availability of accurate
population data obtained in January 1959, when a census of the entire country was
carried out. Although age-specific statistics are not yet complete, information on
total child population is known, and more complete information was expected to be
available by the end of 1959.
ConductofVaccination
Apreliminarypropaganda campaign iscarried outimmediatelybeforebeginning a
vaccination program. To many areas, Dr. Chumakov himself goes with one or more
of his staff members. He addresses first the assembled physicians of the area,
explainingthe program, theorganization, the roleofthephysicians, theirresponsibil-
ities, both during the actual vaccination period and, subsequently, the importance of
close surveillance, and so on. At the same time, there are radio and television
broadcasts (by Dr. Chumakov) explaining to the people the necessity for their full
cooperation if the program is to be successful. Newspapers and billboards carry
notices ofwhere and whenvaccine will be distributed.
The organization for vaccine distribution varies slightly, depending on the nature
of the area, but the principles are the same. In Estonia, for instance, a main town in
each region ofthe Republicwas selected, a town inwhich therewas alaboratorywith
adequate refrigeration facilities. From these centers, teams went out daily, carrying
the vaccine in iced thermos jugs. For rural distribution, teams, usually of three
persons-two nurses and a "feldtscher" or assistant physician-went out to cover an
assigned area. In towns, teams were set up in schools, nurseries, kindergartens,
outpatient clinics, factories, and the like. Aphysician (vrach) supervised the activities
ofseveral teams. Preliminary lists ofvaccinees had been prepared, and data on every
vaccinated person was recorded. In the field, the data were usually in the form of a
503DOROTHY M. HORSTMANN
list, giving name, address, age, type ofvaccine administered, and date ofvaccination.
This information was then collected by the physician and referred to the local
sanitary-epidemiological station, from whence it travelled to the regional sanitary-
epidemiological station. The datawere also transferred to the card keptbyeach local
pediatrician on every child in his district.
Selection ofVaccinees
Since the program was set up as an effort at mass vaccination, there was no
selection ofvaccinees, nor were there any selected control groups. This organization
was deliberate, based first on humanitarian principles, the desire to eliminate
paralytic poliomyelitis completely, and, second, on the idea that spread of the
attenuated strains would destroy the validity of the control group by involuntary
vaccination of an unknown number of contacts. There is therefore no claim by Dr.
Chumakov that a controlled trial has been carried out, but rather that a mass
program has been put into effect. As in any mass program, however, a certain
number of persons living in designated areas were missed, either due to absence,
illness, or reluctance to take part.
VaccineAdministration Schedules
The plan ofvaccination has varied slightly in different Republics. Serial adminis-
tration, starting with Type I, then Type III, then Type II, at monthly intervals was
used in the beginning; the populations in Lithuania and Estonia were vaccinated in
this manner. In Lithuania, a comparison was made between thosevaccinated serially
with the three types given in different order, and with groups receiving a triple
vaccine, given either once or repeated after one month. The serologic tests to be
carried out on thevaccinees are asyet incomplete, butpreliminary databased in part
on studies ofnurserypopulations indicated no significant difference in the end result
ifthe conventional 1-111-I scheme was used, or ifa trivalentvaccine was given. In
many Republics, therefore, trivalent vaccine was used, and, by October 1959, some
5,000,000 children had received this form. Preliminary results with candy vaccine
given to small groups of nursery children indicated that infection and serological
responses were satisfactory. Most recent communications from Dr. Chumakov,
however, indicate that the current plan forvaccinating the entire countrywill call for
four doses ofvaccine: three ofthe monovalent, Type I, Type III, and Type II at four-
to six-week intervals, followed by one dose of trivalent vaccine after an interval of
three to 18 months.
Pre-VaccinalImmune Status ofthePopulation
In all areas where the live poliovirus vaccine programs were carried out, serologi-
cal surveys ofvarying size were made, but in most instances they do not represent a
random sampling because, for the younger age groups, too much reliance seems to
have been placed on so-called "organized children," i.e., children aged 0-3 years
living in nurseries. These children are orphans or have been placed in such institu-
tions because their parents are away or unable to take care ofthem for one reason or
another. Another group heavily represented is a day nursery group ofchildren (aged
eight months to three years) who are deposited by their mothers at the nursery each
morning at 8 A.M. and collected at 4 P.M. Children attending such institutions
represent about 15 percent ofthe population, aged six months to three years. These
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two groups make up 100 percent of the 0-3-year age group surveyed, but obviously
are not representative of the population at large. The age group four to seven was
also drawn from institutionalized children to a great extent and from kindergartens.
School children account for the age groups seven to 14, and factory workers largely
for the adults. Blood specimens are usuallycollected bynurses, specially trained, but
in some instances by physicians. Ordinary syringes are used, and 3-5 ml taken from
antecubital or scalpveins and occasionally from neckveins.
Surveillance
Follow-up to identifypoliomyelitis cases, particularlythosewhich might develop in
vaccinated children, seems to beverygood. As an infectious disease, it has a priority,
and, following the propaganda associated with the live virus vaccine program, it has
particular prominence. In each area, the teams responsible forvaccination were also
concernedwith surveillance. InTashkent,wherevaccinewas administeredbeginning
on July 19, during an epidemic, each home was visited every five to six days until
mid-September, in order to check on possible cases. In general, however, the
pediatrician responsible for the area is the one who sees the sick child, makes a
diagnosis, and notifies the local sanitary-epidemiological station of the case. An
epidemiologist then visits the home ofthe child, fills out an elaborate epidemiologi-
cal history chart, enquires about illness among contacts, sometimes collects speci-
mens from those with suspicious illness, and the like.
The Ministry of Health in Moscow has set up a special notification system for
poliomyelitis cases, which requires that the local physician notify by telephone or
telegraph the regional sanitary-epidemiological station, which in turn telephones or
telegraphs the central sanitary-epidemiological station of the Republic. There is no
difficulty in establishing whether the child has been vaccinated or not, since this
information is on file in the local pediatrician's records and also at the sanitary-
epidemiological station. All suspicious cases, i.e., all cases with signs of acute
infection ofthe central nervous system, are hospitalized; in remote areas, transporta-
tion to the hospital maybe arranged byplane.
ReportingofCases
A special-and complicated-form has been provided for the reporting of polio-
myelitis cases. As in most reporting systems, there is some variation from place to
place in the completeness and speed withwhich cases are notified. Under the USSR
system, however, it would seem that all paralytic cases are seen and reported. It is
probable that some mild cases of aseptic meningitis might slip through, but, in
general, overreporting rather than underreporting seems to be the rule. The team of
specialists which is sent to confirm the diagnosis not infrequently eliminates the case
as "notpoliomyelitis."
Laboratory Confirmation ofCases
The collection of specimens from suspected poliomyelitis cases also varies some-
what, depending on the area. In Karaganda, Tashkent, Moscow city, the collections
are good; though in Moscow region, for example, which is largely rural, delays and
failures to collect specimens are problems. The routine is to collect at least two fecal
specimens during the acute phase ofillness and at least an acute and a convalescent
blood specimen. Specimens are sent first to the local sanitary-epidemiological
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station, then towhatever laboratory hasbeen designated for testing-a regional one,
or the Moscow laboratories of Dr. Chumakov. In some areas, fecal specimens are
divided, part beingtested inthe regional laboratories and partbeing sent to Moscow.
Serological tests are performed largely in the Moscow laboratories, although, in a
few areas, the regional laboratories also perform some of the tests. It is hard to
visualize any state, particularly the larger ones in the United States, where the
laboratory confirmation of the clinically diagnosed cases of poliomyelitis is so
universally carried out.
EXAMPLES OF DIFFERENT VACCINATION PROGRAMS
Details on the conduct of vaccination and preliminary results were available for
only some ofthe Republics at the time ofmyvisit. These particulars are given in the
following sections.
VACCINATION IN ESTONIA
Estonia has had one ofthe highest rates ofpoliomyelitis in the Soviet Union. The
largest epidemic recorded occurred in 1958, when the attack rate reached 89 per
100,000. The age distribution was not unlike that ofSweden, with 20 to 30 percent of
cases in adults over 20years. Killed (Salk-type) vaccine hasbeen used in the past few
years on a modest scale by the Ministry ofHealth ofthe Republic; exact data on the
percentage vaccinated in each age group were not available.
Serological Survey
In spite of the tremendous epidemic of 1958, a considerable number of suscepti-
bles to one or more types ofpoliovirus remained in the population, as shownby data
presented by Dr. Chumakov in June 1959 [2]. Of the 519 children and adults
surveyed, the percentage lacking antibodies to all three types was close to 50 percent
for children under ten; for the individual types, the figures were 44 percent, 25
percent, and 51 percent for Types I, II, and III, respectively. Such results indicate a
large segment ofsusceptibles in this population.
Vaccination Program
Estonia was the first Republic in which Dr. Chumakov and his team undertook a
massvaccination. By May 10, 1959, a total of657,000 ofthe population of 1.1 million
had beenvaccinated, including about 60-70 percent ofthe children up to age 15, and
50 percent of those 16-50 years. Vaccination continued throughout the summer of
1959, chiefly among the youngest children, so that the total number ofvaccinees by
September 1 was approximately 716,000. The schedule used was Type I, followed at
monthly intervals byType III, and Type II. Coincidentally an extensive program was
set up for following virus excretion and serological conversion in vaccinees and their
contacts in a number ofgroups, including children in nurseries, school children, and
young adult students. In all, some 10,000 fecal specimens and several thousand
bloods were collected. Dr. Drosdov, Dr. Shirman, and two technicians went from the
Moscow Institute for Poliomyelitis Research to the Laboratory in Tallinn, where
they remained for several months, through the vaccination period. The bulk of the
specimens are nowbeing tested in Moscow.
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Clinical Surveillance
In Estonia, a center for the Republic was established for this purpose in Tartu,
under the direction of Professor Randam, who has had many years of experience
with poliomyelitis. In addition, a special epidemiological bureau was organized to
survey all poliomyelitis cases, suspected cases, and contacts. An effort was made to
obtain three fecal specimens during the acute phase, and two to three acute and
convalescent blood specimens. Laboratory tests are currently underway.
Effectofthe Vaccination Program
The vaccination campaign completed in May was followed by a reduction in the
number ofcases and, most striking, absence of the usual summer rise. Furthermore,
therewas no suggestion on clinical or epidemiological evidence that thevaccinevirus
in spreading among susceptible contacts had acquired enhanced virulence after
multiple passages.
VACCINATION IN TASHKENT
This region is an area of particular interest because a mass vaccination program
was carried out there in July and August 1959, during the course ofa sharp outbreak
ofpoliomyelitis. Discussions ofvarious aspects ofthe activitieswere held inTashkent
with the Director of the Uzbek Serum and Vaccine Institute, Dr. Inogamov, and his
staffand Dr. Boito, head ofthe Sanitary-Epidemiologic Department ofthe Republic.
The population of Tashkent has grown sharply in recent years. The estimated
number of inhabitants in 1924-26 was 200,000. The January 1959 census listed
911,000. The rise is largely natural growth, but reinforced by great migrations from
the west during the war years, 1941-42. The way of life and standards of living until
recentlywere similar to those ofunderdeveloped countries ofthe Middle East. Over
the course of the last 40 years, however, there has been a steady change. Tashkent
has become a center of the textile industry, and with industrialization have come
higher living standards, better housing, better medical care, and so on.
History ofPoliomyelitis in theArea
Uzbekistan has had one of the lowest poliomyelitis attack rates of any Republic.
Only sporadic cases in young children have been notified in the past, but, as in
neighboring Kazakhstan, there has been a gradual increase in their number in the
past decade. Beginning in June 1959, the first epidemic appeared. It centered in
Tashkent, but an increased incidence was noted throughout the Republic. As
previously, the youngest age group was involved; 80 percent ofcaseswere in children
under four years. By mid-July, the number of cases was increasing rapidly; at this
time, it was decided to try to check the epidemic by a rapid mass application of
trivalent live poliovirus vaccine covering all children under 15 years of age. This
program was begun on July 19, under the personal direction ofDr. Chumakov.
Organization ofthe Vaccination Program
Because of the emergency nature of the vaccination program in Tashkent, a
vigorous propaganda campaign was carried on for several days via the television,
radio, and press, with Dr. Chumakov playing a prominent role. The 2,000 physicians
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ofthe city, regardless oftheirspecialties, were asked to assist. The city is divided into
23 districts, and the health station in each provided a list ofchildren in its area.
July 19 was a Sunday. All families with children were urged, through media
communications, to remain at home until visited by avaccination team. Vaccine was
given by ordinary medicine dropper in a spoon (provided by the family) with water;
the oral dose was two drops, which amount had been calculated to contain approxi-
mately 100,000 TCD50 ofeach ofthe three types. The number ofchildren vaccinated
on July 19 was 182,000; on July 22-23, 122,000, and on August 12, 160,000. The total
number of vaccinees was >400,000, which represents almost the entire estimated
population of Tashkent under 15 years, according to the January 1959 census.
Although the vaccination was voluntary, considerable pressure was exerted in the
course oftelevision and radio propaganda, taking advantage ofthe fear experienced
by all parents in the face of a poliomyelitis epidemic. The response was thus quite
close to 100 percent. Approximately sixweeks after initialvaccination, a second dose
was given tovirtually all who had received the first; the administration ofthe second
dose covered a period offour days.
Collection and TestingofSpecimens
Fecal specimens were collected from about 100 cases during the early part of the
epidemic, before vaccination was carried out. Few of them had been tested by
September 1959, but five strains ofType I, one ofType III, and a mixture ofTypes I
and III had already been isolated. Several untypeable agents-possibly mixtures-
had also been encountered. It would seem likely that in a population such as that of
Tashkent, inapparent infections with various enteroviruses would be common in the
youngest age group.
After vaccination, specimens were collected from all definite and suspected cases
of poliomyelitis; throat swabs were taken from some, and fecal samples were
obtained twice during the first week of admission. Acute and convalescent blood
samples were also collected.
Laboratory studies, including virus isolations from fecal specimens and flies, and
serological tests, are in progress in the newly established poliomyelitis unit at the
Tashkent Serum and Vaccine Institute. Preliminary results indicate that Type I was
active, but all isolates had not yet been typed. The extensive laboratory program
planned is ambitious for a small unit; itwill doubtlessbe some time before results are
available, in spite ofthe constant advice and support ofDr. Chumakov's laboratoryin
Moscow.
Course oftheEpidemic
A total ofapproximately 400 cases occurred, 80 percent ofwhich were in children
under four. Followingvaccination, the epidemic fell offsharply. It was short, lasting
only some two and a halfmonths. This duration was in contrast to the experience of
nearby Alma Ata, Kazakhstan, a city of similar size and type, where a first epidemic
occurred in 1954 and lasted over a six-month period. The difference suggests that
oral vaccine may have played a role in shortening the Tashkent epidemic. Further-
more, it is clear that mass vaccination of the child population in the middle of a
summer outbreak did not increase the incidence ofpoliomyelitis.
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LIVE VIRUS VACCINE WORK DIRECTED BY
DR. A.A. SMORODINTSEV
Several days were spent in Leningrad, reviewing with Dr. A.A. Smorodintsev the
vaccination programs under his direction in Latvia, Moldavia, and Byelorussia.
Laboratories
Dr. Smorodintsev is head of the Virology Department of the Institute of Experi-
mental Medicine of the USSR Academy of Medical Science. The Department
occupies a floor of the Institute, which was built in the 1930s. The building seems
older than this, and the rooms are apt to be dark and cold. The staff, which seemed
very able indeed, consists of 16 physicians, 43 technicians, and a number of bottle
washers. Laboratory techniques were similar to those elsewhere in the USSR. In
some of the pH neutralization tests, plastic plates obtained from Denmark were
being used. The CF test is performed according to the drop method, utilizing a
complicated mechanical dropper designed by Dr. A. Selivanoff.
THE POLIOVIRUS VACCINATION PROGRAMS IN BYELORUSSIA
AND MOLDAVIA
The organization ofthe programs in Moldavia and Byelorussia was similar to that
in other Republics, taking advantage ofthe same type ofextensive medical and other
facilities. The period ofmassvaccinationwas March toJune 1959. Vaccination teams
were set up invarious schools, clinics, and the like. About 14 days were required for
completing the administration ofType I vaccine; after two weeks, the second round
was given, Types II and III together. Registration ofvaccinees and reporting ofcases
was as in other Republics.
Laboratory Tests
All pre- and post-vaccinal serological and virological tests on materials from
Moldavia and Byelorussia have been performed in Dr. Smorodintsev's laboratory in
Leningrad. In some instances, the fecal specimens were divided, part being sent to
Leningrad, and part being tested locally, in Minsk (Byelorussia) or in the virus
laboratory of the Institute of Epidemiology in Kishinev (Moldavia). In these two
laboratories, monkey kidney cells are received by air from the Moscow Institute for
Poliomyelitis Research; in addition, human embryonic fibroblast cultures from
specimens obtained from local hospitals are also used.
Serological surveys carried out in both Republics were among nursery school
children for the younger age groups, and at schools and factories for older individu-
als. The results ofthe testswere notyet available at the time ofmyvisit.
Poliomyelitis in Moldavia andByelorussia in 1959
In both Republics following the March-June 1959vaccination program, there was
a marked reduction in the numbers ofcases compared to previousyears. The rates in
the cities where oral vaccine had been given were significantly lower than in similar
unvaccinated areas. Furthermore, there was no indication that spread ofthe vaccine
strains had resulted in enhanced virulence and the appearance ofcases.
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VACCINATION IN LATVIA
Vaccination in Latvia was also carried out under Dr. Smorodintsev's direction,
during April and May 1959. At the poliomyelitis laboratory of the Institute of
Microbiology ofthe Latvian SSR, discussions were held with the Director, Dr. A.M.
Kirchenstein and his associates, and at the Children's Hospital in Riga with Dr. N.
Pakalnin, chiefofthe neuroinfection ward, and his clinical staff.
History ofPoliomyelitis in Latvia
Epidemic poliomyelitis in Latvia has followed a pattern similar to that in the
nearby Scandinavian countries, with increasingly severe outbreaks. The population
ofthe Republic is about 2,000,000, and ofthe capital city, Riga, 600,000. Attack rates
have always been highest in the cities, particularly Riga. The most severe epidemic
occurred in 1956, in which there were 528 cases, an attack rate of 88 per 100,000.
During 1957, an extensive programusingthe Salk-typevaccine hadbeen undertaken,
and 82,000 children under 15 were given two doses followed by a third dose in 1958.
In the city of Riga, virtually all children ofthis age group were so vaccinated; in the
rest of the Republic, approximately 10-15 percent of the child population had
received two or more doses. Although cases in older children and young adults
continue to occur, there has been some shift recently toward a higher incidence in
young children, i.e., under five years, particularly in the cities.
TheMicrobiology Institute in Riga
This institute, which operates under the auspices of The Latvian Academy of
Medical Sciences,wasconstructed inthe early 1930s. Itconsistsofthreeorfoursmall
stucco laboratory and administrative buildings, three stories high, and a number of
animal quarters. The laboratories are simple and well kept; there are many glass-
partitioned working units. In the biochemistry and biophysics building, there is an
electron microscope and, in addition, avariety ofelectronic equipment.
The Poliomyelitis Department was set up in 1956, at which time several of the
senior staff spent some time in Moscow at the Institute for Poliomyelitis Research
under Dr. Chumakov in order to obtain training in tissue culture and poliomyelitis
work. The present staffconsists ofnine physicians and 15 technicians. The physicians
are knowledgeable, young, conscientious, and enthusiastic. They look forward
eagerly to continued work in the enterovirus field.
Laboratory Tests
Virus isolation isperformed usinghuman embryonictissue,which isreceived twice
weekly from abortions performed at the hospitals in Riga. In serologic tests, the
methods employed are the same as those used in Moscow and other laboratories.
The Children's Hospital in Riga
This institution is an 800-bed hospital, probably about 25 years old, on the
outskirts of the city. The deputy director, Dr. N. Pakalnin, is also the chief of the
neuroinfection ward and has long been particularly interested in poliomyelitis. It is
obvious that he has had great experience with the disease; he speaks English fluently
and is thoroughly familiarwith the clinical literature on poliomyelitis in English. The
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medical staff, in addition to Dr. Pakalnin, are experienced physicians, and the
standards ofmedical and nursing care are high.
The Live Virus Vaccination Program in Latvia
The Republic is divided into 44 provinces, or regions; vaccine was administered in
21 ofthese, the other 23 being left as controls. In the past, the 21 vaccinated regions,
which include the five cities, accounted for approximately 88 percent ofthe poliomy-
elitiscases,while inthe control, non-vaccinated regions an averageofonly 12percent
ofthe total cases occurred.
During April and May 1959, approximately 413,000 individuals received mono-
valent Type I oral vaccine; one month later, 376,464 of these received Types II and
III combined. The focus was primarily on children under 15 and on young adults;
approximately 65 percent ofthese groupswerevaccinated. As elsewhere, the regions
to be vaccinated were divided, and teams consisting ofone physician and two nurses
covered a given population group. The vaccine was administered at polyclinics,
nurseries, schools, and various special vaccine clinics. Each vaccinee was registered,
and the records were forwarded to the ChiefEpidemiologist in Riga.
Serological Surveys
Apre-vaccinal surveywascarried out in seven selected regions in different partsof
the Republic, exclusive ofRiga. The seraweretested in Leningrad, in Dr. Smorodint-
sev's laboratory. Details ofthe results are notpresently available, but Dr. Smorodint-
sev has reported that in Latvia "serological examination of selected groups of
children ofvarious ages prior to vaccination showed that 42 percent of them were
negative to Type I, and about 40 percent to Types II and III." The results of a
post-vaccinal survey of 500 persons-not necessarily the same ones as those in the
pre-vaccinal survey-are notyet available.
Surveillance
Since Latvia is small, the most distant point from the capital being 200 kilometers,
virtually all suspected cases ofpoliomyelitis could be referred to the special poliomy-
elitis ward-set up in the Children's Hospital in Riga; such was the practice in 1959.
During the months June-October, following completion ofthe vaccination program,
therewere 14cases ofparalyticpoliomyelitis scattered throughout the Republic. Use
ofSalkvaccine in 1957 and 1958, following the large 1956epidemic, and the highoral
vaccine coverage in 1959 no doubt contributed to this low incidence. No clinical or
epidemiologic evidence emerged that livevirusvaccine contact spread enhanced the
virulence ofthevirus or caused paralytic cases.
SUMMARY: USSR
Extensive mass programs ofpoliomyelitis vaccination using Sabin's strains ofvirus
have been carried out in the USSR, beginning in January 1959. To date, some
10-15,000,000 persons have been vaccinated. The evidence seems conclusive that
these strains are safe, both to thevaccinees and to theircommunities. Surveillance of
cases is good, and it seems very unlikely that paralytic cases of poliomyelitis would
have been missed. The marked reduction of cases in 1959 in orally vaccinated
Republics suggests that thevaccine mayhave played a significant role in reducingthe
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incidence of paralytic poliomyelitis. Compared to the pattern of rising incidence in
the past fewyears, and the five-year averages, the low incidence in 1959 stands out.
The standards oflaboratoryworkin the areas evaluated are high. The facilities are
adequate, and the laboratorypersonnel, both attheprofessional andtechnical levels,
is extensive; however, there is often some delay in carrying out laboratory investiga-
tions of cases occurring in vaccinated areas. In view of the enormous amount of
laboratory work to be completed in a year of many vaccination programs, it is
understandable that final results are slow in coming. When completed, pre- and
post-vaccinal serological surveys should aid greatly in estimating the effectiveness of
the Sabin strains of attenuated live virus vaccine administered in various ways and
undervarious epidemiological circumstances.
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